Replies to post #209649 on Biotech Values

[DewDiligence]

RVNC—Anyone see an issue for patient questionnaire to be included for RT002 efficacy review/data?

I do not understand what you mean—please clarify.

p.s. The "weakness" of the share price has to be put in perspective. As I'm typing, RVNC is still up 40% since the US presidential election.